Continuous Infusion of Prostacyclin Normalizes Plasma Markers of Endothelial Cell Injury and Platelet Aggregation in Primary Pulmonary Hypertension
- 4 November 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 96 (9) , 2782-2784
- https://doi.org/10.1161/01.cir.96.9.2782
Abstract
Background Primary pulmonary hypertension (PPH) is characterized by vascular injury of pulmonary arterioles, in which endothelial dysfunction may play a major role. Although continuous infusion of ...Keywords
This publication has 10 references indexed in Scilit:
- Primary Pulmonary HypertensionNew England Journal of Medicine, 1997
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Survival in Primary Pulmonary Hypertension with Long-Term Continuous Intravenous ProstacyclinAnnals of Internal Medicine, 1994
- Abnormal Multimeric and Oligomeric Composition Is Associated With Enhanced Endothelial Expression of von Willebrand Factor in Pulmonary HypertensionChest, 1993
- An Imbalance between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary HypertensionNew England Journal of Medicine, 1992
- Heterogeneity of Pathologic Lesions in Familial Primary Pulmonary HypertensionAmerican Review of Respiratory Disease, 1988
- Primary Pulmonary HypertensionAnnals of Internal Medicine, 1987
- Comparison of primary plexogenic arteriopathy in adults and children. A morphometric study in 40 patients.Heart, 1985
- Vessel injury, platelet adherence, and platelet survival.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983